{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T07:29:02Z","timestamp":1775806142179,"version":"3.50.1"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T00:00:00Z","timestamp":1762128000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T00:00:00Z","timestamp":1762128000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"2022 Shandong Province Medical and Health Technology Development Plan Project","award":["NO.202203040878"],"award-info":[{"award-number":["NO.202203040878"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Discov Onc"],"DOI":"10.1007\/s12672-025-03869-2","type":"journal-article","created":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T10:48:36Z","timestamp":1762166916000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["LncRNA NEAT1 modulates myeloma cell autophagy and apoptosis by competitively binding miR-195-5p to regulate CEBPA"],"prefix":"10.1007","volume":"16","author":[{"given":"Ting","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongyue","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Tao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bin","family":"Bai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiuhui","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bingyun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yingchao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xueyong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,11,3]]},"reference":[{"issue":"5","key":"3869_CR1","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1001\/jama.2022.0003","volume":"327","author":"AJ Cowan","year":"2022","unstructured":"Cowan AJ, Green DJ, Kwok M, Lee S, Coffey DG, Holmberg LA, et al. Diagnosis and management of multiple myeloma: A review. JAMA. 2022;327(5):464\u201377.","journal-title":"JAMA"},{"issue":"1","key":"3869_CR2","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s43556-024-00188-w","volume":"5","author":"Q Lu","year":"2024","unstructured":"Lu Q, Yang D, Li H, Niu T, Tong A. Multiple myeloma: signaling pathways and targeted therapy. Mol Biomed. 2024;5(1):25.","journal-title":"Mol Biomed"},{"issue":"1","key":"3869_CR3","doi-asserted-by":"publisher","first-page":"6960","DOI":"10.1038\/s41467-021-26951-z","volume":"12","author":"SM Tirier","year":"2021","unstructured":"Tirier SM, Mallm JP, Steiger S, Poos AM, Awwad MHS, Giesen N, et al. Subclone-specific microenvironmental impact and drug response in refractory multiple myeloma revealed by single-cell transcriptomics. Nat Commun. 2021;12(1):6960.","journal-title":"Nat Commun"},{"issue":"16","key":"3869_CR4","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.2217\/bmm-2022-0349","volume":"16","author":"S Leng","year":"2022","unstructured":"Leng S, Qu H, Lv X, Liu X. Role of NcRNA in multiple myeloma. Biomark Med. 2022;16(16):1181\u201391.","journal-title":"Biomark Med"},{"issue":"2","key":"3869_CR5","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/j.apsb.2020.10.001","volume":"11","author":"Y Chen","year":"2021","unstructured":"Chen Y, Li Z, Chen X, Zhang S. Long non-coding rnas: from disease code to drug role. Acta Pharm Sin B. 2021;11(2):340\u201354.","journal-title":"Acta Pharm Sin B"},{"issue":"12","key":"3869_CR6","doi-asserted-by":"publisher","first-page":"2226","DOI":"10.1158\/1078-0432.CCR-22-3714","volume":"29","author":"J Toker","year":"2023","unstructured":"Toker J, Iorgulescu JB, Ling AL, Villa GR, Gadet J, Parida L, et al. Clinical importance of the LncRNA NEAT1 in cancer patients treated with immune checkpoint inhibitors. Clin Cancer Res. 2023;29(12):2226\u201338.","journal-title":"Clin Cancer Res"},{"issue":"9","key":"3869_CR7","doi-asserted-by":"publisher","first-page":"e23399","DOI":"10.1002\/jcla.23399","volume":"34","author":"H Yu","year":"2020","unstructured":"Yu H, Peng S, Chen X, Han S, Luo J. Long non-coding RNA NEAT1 serves as a novel biomarker for treatment response and survival profiles via microRNA-125a in multiple myeloma. J Clin Lab Anal. 2020;34(9):e23399.","journal-title":"J Clin Lab Anal"},{"key":"3869_CR8","unstructured":"Tawana K, Fitzgibbon J. CEBPA-associated familial acute myeloid leukemia (AML). In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A (eds.). Gene reviews. Seattle (WA) 1993."},{"issue":"5","key":"3869_CR9","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1111\/cge.14693","volume":"107","author":"MN Spangenberg","year":"2025","unstructured":"Spangenberg MN, Boada M, Ottati C, Vazquez L, Catalan A, Grille S. Unusual Co-Occurrence of multiple myeloma and AML in a patient with germline CEBPA Variant. Expanding the spectrum of hereditary hematologic malignancies. Clin Genet. 2025;107(5):576\u20138.","journal-title":"Clin Genet"},{"key":"3869_CR10","doi-asserted-by":"publisher","first-page":"21","DOI":"10.3390\/cancers13215258","volume":"13","author":"SR Moura","year":"2021","unstructured":"Moura SR, Abreu H, Cunha C, Ribeiro-Machado C, Oliveira C, Barbosa MA, et al. Circulating MicroRNAs correlate with multiple myeloma and skeletal osteolytic lesions. Cancers (Basel). 2021;13:21.","journal-title":"Cancers (Basel)"},{"key":"3869_CR11","doi-asserted-by":"publisher","unstructured":"Siqueira E, Velasco CD, Tarrason A, Soler M, Srinivas T, Setien F et al. NEAT1-mediated regulation of proteostasis and mRNA localization impacts autophagy dysregulation in Rett syndrome. Nucleic Acids Res. 2025;53(4). https:\/\/doi.org\/10.1093\/nar\/gkaf074","DOI":"10.1093\/nar\/gkaf074"},{"issue":"11","key":"3869_CR12","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1007\/s00592-023-02131-x","volume":"60","author":"K Wu","year":"2023","unstructured":"Wu K, Huang S, Zheng F, Liu Y. The CEBPA-FGF21 regulatory network May participate in the T2DM-induced skeletal muscle atrophy by regulating the autophagy-lysosomal pathway. Acta Diabetol. 2023;60(11):1491\u2013503.","journal-title":"Acta Diabetol"},{"issue":"4","key":"3869_CR13","doi-asserted-by":"publisher","first-page":"1528","DOI":"10.1007\/s10528-023-10330-y","volume":"61","author":"L Fu","year":"2023","unstructured":"Fu L, Li Z, Wu Y, Zhu T, Ma Z, Dong L, et al. Hsa-miR-195-5p inhibits autophagy and gemcitabine resistance of lung adenocarcinoma cells via E2F7\/CEP55. Biochem Genet. 2023;61(4):1528\u201347.","journal-title":"Biochem Genet"},{"issue":"1","key":"3869_CR14","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s12943-024-01944-w","volume":"23","author":"C Zhang","year":"2024","unstructured":"Zhang C, Yu Z, Yang S, Liu Y, Song J, Mao J, et al. ZNF460-mediated circRPPH1 promotes TNBC progression through ITGA5-induced FAK\/PI3K\/AKT activation in a CeRNA manner. Mol Cancer. 2024;23(1):33.","journal-title":"Mol Cancer"},{"key":"3869_CR15","doi-asserted-by":"publisher","first-page":"806137","DOI":"10.3389\/fonc.2022.806137","volume":"12","author":"L Su","year":"2022","unstructured":"Su L, Shi YY, Liu ZY, Gao SJ. Acute myeloid leukemia with CEBPA mutations: current progress and future directions. Front Oncol. 2022;12:806137.","journal-title":"Front Oncol"},{"issue":"2","key":"3869_CR16","doi-asserted-by":"publisher","first-page":"839","DOI":"10.3892\/ijmm.2020.4624","volume":"46","author":"Y Wang","year":"2020","unstructured":"Wang Y, Zhang CX, Ge SL, Gong WH. CTBP1\u2013AS2 inhibits proliferation and induces autophagy in ox\u2013LDL\u2013stimulated vascular smooth muscle cells by regulating miR\u2013195\u20135p\/ATG14. Int J Mol Med. 2020;46(2):839\u201348.","journal-title":"Int J Mol Med"},{"key":"3869_CR17","doi-asserted-by":"publisher","unstructured":"Bashiri H, Tabatabaeian H, Autophagy. A potential therapeutic target to tackle drug resistance in multiple myeloma. Int J Mol Sci. 2023;24(7):6019. https:\/\/doi.org\/10.3390\/ijms24076019","DOI":"10.3390\/ijms24076019"},{"key":"3869_CR18","doi-asserted-by":"publisher","unstructured":"Al-Odat OS, Guirguis DA, Schmalbach NK, Yao G, Budak-Alpdogan T, Jonnalagadda SC et al. Autophagy and apoptosis: current challenges of treatment and drug resistance in multiple myeloma. Int J Mol Sci. 2022;24(1):644. https:\/\/doi.org\/10.3390\/ijms24010644","DOI":"10.3390\/ijms24010644"},{"issue":"21","key":"3869_CR19","doi-asserted-by":"publisher","first-page":"4693","DOI":"10.1158\/0008-5472.CAN-20-1357","volume":"80","author":"N Manfrini","year":"2020","unstructured":"Manfrini N, Mancino M, Miluzio A, Oliveto S, Balestra M, Calamita P, et al. FAM46C and FNDC3A are multiple myeloma tumor suppressors that act in concert to impair clearing of protein aggregates and autophagy. Cancer Res. 2020;80(21):4693\u2013706.","journal-title":"Cancer Res"},{"issue":"12","key":"3869_CR20","doi-asserted-by":"publisher","first-page":"2103","DOI":"10.4161\/auto.26563","volume":"9","author":"SH Ro","year":"2013","unstructured":"Ro SH, Jung CH, Hahn WS, Xu X, Kim YM, Yun YS, et al. Distinct functions of Ulk1 and Ulk2 in the regulation of lipid metabolism in adipocytes. Autophagy. 2013;9(12):2103\u201314.","journal-title":"Autophagy"},{"issue":"6","key":"3869_CR21","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1016\/j.tranon.2018.08.014","volume":"11","author":"V Desantis","year":"2018","unstructured":"Desantis V, Saltarella I, Lamanuzzi A, Mariggi\u00f2 MA, Racanelli V, Vacca A, et al. Autophagy: A new mechanism of prosurvival and drug resistance in multiple myeloma. Translational Oncol. 2018;11(6):1350\u20137.","journal-title":"Translational Oncol"},{"issue":"4","key":"3869_CR22","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1136\/gutjnl-2024-334266","volume":"74","author":"Z Altan","year":"2025","unstructured":"Altan Z, Johnson R. Targeting Wnt signalling through LINC02418: insights from CRISPR screens. Gut. 2025;74(4):513\u20135.","journal-title":"Gut"}],"container-title":["Discover Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-025-03869-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12672-025-03869-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-025-03869-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T10:48:38Z","timestamp":1762166918000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12672-025-03869-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,3]]},"references-count":22,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3869"],"URL":"https:\/\/doi.org\/10.1007\/s12672-025-03869-2","relation":{},"ISSN":["2730-6011"],"issn-type":[{"value":"2730-6011","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,3]]},"assertion":[{"value":"17 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All the experimental procedures involving animals were conducted in accordance with ARRIVE guidelines and approved by the Animal Ethics Committee of TSecond People\u2019s Hospital of Liaocheng Affiliated to Shandong First Medical University (Approval number:2022-06). The maximum subcutaneous tumor diameter allowed by the ethics committee of our hospital in nude mice was 15\u00a0mm, and this study met this criterion.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors gave final approval of the version to be published.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"2012"}}